Edward Lanphier of Sangamo on engineering genetic cures – at Stem Cells USA

Posted: December 27, 2012 at 6:40 am




Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA RM Congress 2012
Edward Lanphier, CEO of Sangamo, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Engineering genetic cures: employing zinc finger nucleases (ZFNs) in stem cells. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:74 0ratingsTime:24:15More inScience Technology

The rest is here:
Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA

Related Posts

Comments are closed.

Archives